Icon

RELENZA (nda021036)- (5MG)

ZANAMIVIR GLAXOSMITHKLINE
5MG
No No
2014-Dec-15 Expired
None None
None No
RELENZA, an influenza virus neuraminidase inhibitor (NAI), is indicated for: *Treatment of acute, uncomplicated influenza type A and B infections in patients aged 7 years and older who have been symptomatic for no more than 2 days. *Prophylaxis of influenza in patients aged 5 years and older.
0 0 0
Total Other Developers None
Drugs with Suitability No
5MG ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.